Consumers, State Medicaid Programs Benefit from Neurontin Settlement
SEATTLE -- A $430 million settlement with makers of a prescription epilepsy drug will return millions of dollars to Washington's Medicaid program and provide money to offset the company's improper efforts to market the drug Neurontin for other purposes, Attorney General Christine Gregoire announced today.